The role of MGA in the pathogenesis of Richter Transformation

Collaborative Subcontract with University of Texas M.D. Anderson Cancer Center and Dr. Melnick

Translating molecular profiles into treatment approaches to target disparities in lymphoma

Defining Mechanisms of Resistance to Therapy in BTK-mutant Chronic Lymphocytic Leukemia

Dissect MGA-mutant lymphomagenesis towards novel rational therapeutics for DLBCL and Richter transformation.

Uncovering MGA-driven epigenetic reprogramming in Richter's syndrome

Dana-Farber Cancer Institute Donor Funds Sub award Agreement

Characterizing and targeting aberrant NOTCH1 signaling in Richter's syndrome

Define the evolutionary trajectories of CLL undergoing Richter transformation through single-cell multi-omics

Defining the epigenetic landscape and therapeutic vulnerabilities of Richter's syndrome in CRISPR-based mouse models

Identifying B cell developmental changes and therapeutic vulnerabilities of MGA-mutant Richter's syndrome